Home > Boards > US OTC > Biotechs >

Cortendo AB (publ) (CRTOF)

CRTOF RSS Feed
Add CRTOF Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 8/22/2015 4:22:33 PM - Followers: 0 - Board type: Free - Posts Today: 0

Cortendo AB (publ) Box 47 Partille, 433 21 Sweden Phone: 46 31 26 30 10 Fax: 46 31 26 30 10 Website: http://www.cortendo.com Cortendo AB (publ), a biopharmaceutical company, identifies, develops, and commercializes the treatments for orphan endocrine diseases in Europe and the United States. The company’s product pipeline includes COR-003 (levoketoconazole), which is in Phase III clinical trials for the treatment of endogenous Cushing’s syndrome. It is also developing COR-004, a second-generation antisense drug to treat acromegaly; and COR-005, a somatostatin ligand for metabolic stabilization of the peptides, as well as BioPancreate-2001, which is in pre-clinical trials for type 1 and 2 diabetes patients. Cortendo AB (publ) was founded in 1996 and is based in Partille, Sweden.
CRTOF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#1   $CRTOF recent news/filings stocktrademan 08/22/15 04:22:33 PM
PostSubject